Evidence map›Paper›PMID 35757577›Full record

ArticlePreventive medicine reports2022

Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018.

Sarah Bissig, Lamprini Syrogiannouli, Rémi Schneider, Kali Tal, Kevin Selby, Cinzia Del Giovane, Jean-Luc Bulliard, Oliver Senn, Cyril Ducros, Christian P R Schmid and 2 more

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Listening to patients: A qualitative study on diagnostic delay, coping strategies and stigma in early-onset colorectal cancer.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Sarah BissigInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Lamprini SyrogiannouliInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Rémi SchneiderInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Kali TalInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Kevin SelbyCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Cinzia Del GiovaneInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Jean-Luc BulliardCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Oliver SennInstitute of Primary Care, University and University Hospital of Zurich, Zurich, Switzerland.
Cyril DucrosCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Christian P R SchmidCSS Institute for Empirical Health Economics, Tribschenstrasse 21, Lucerne, Switzerland.
Urs MarbetDivision of Gastroenterology and Hepatology Cantonal Hospital of Uri, Altdorf, Switzerland.
Reto AuerInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
University of Bern · CHCentre universitaire de médecine générale et santé publique, Lausanne · CHUniversity of Lausanne · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first canton in Switzerland to implement an organized colorectal cancer screening program (OSP) was Uri. Starting in 2013, it offered 50-69-year-olds free testing with colonoscopy every 10 years or fecal occult blood test (FOBT) every 2 years. We tested the association between the OSP and testing rates over time. We analyzed claims data of 50-69-year-olds from Uri and neighboring cantons (NB) provided by a large health insurance and complemented it with data from the OSP. We fitted multivariate adjusted logistic regression models to compare overall testing rates and by method (colonoscopy or FOBT/both) We computed the 2018 rate of the population up-to-date with testing (colonoscopy within 9 years/FOBT within 2 years). Yearly overall testing rates in Uri increased from 8.7% in 2010 to 10.8% in 2018 and from 6.5% to 7.9% in NB. In Uri, the proportion tested with FOBT/both increased from 4.7% to 6.0% but decreased from 2.8% to 1.1% in NB. Testing by FOBT/both increased more between 2015 and 2018 than 2010-2012 in Uri than in NB (OR:2.1[95%CI:1.8-2.4]), it increased less for colonoscopy (OR:0.60[95%CI:0.51-0.70]), with no change in overall CRC testing (OR:0.91[95%CI:0.81-1.02]). In 2018 in Uri, 42.5% were up-to-date with testing (FOBT/both:9.2%, colonoscopy:35.7%); in NBs, 40.7% (FOBT/both:2.7%, colonoscopy:39%). Yearly FOBT rates in Uri were always higher than in NB. Though the OSP in Uri was not associated with a greater increase in overall testing rates, the OSP was associated with increased FOBT.

Indexed as

AL, Swiss analysis list for laboratory measuresclaims datacolonoscopycolorectal cancerCRC, colorectal cancerfecal occult blood testFOBT, gFOBT, iFOBT, fecal occult blood test, guaiac or immunochemical based (also called FIT)FSO, federal statistics officehealth insuranceNB, neighboring cantonsorganized screening programOSP, organized screening programPCG, pharmacy based cost groupsscreeningSHS, swiss health surveyTARMED, Swiss ambulant procedures codestesting ratesUri, the canton of Uri

Identifiers

PMID35757577
PMCPMC9218582
OpenAlexW4281747368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.